Trilogy of papers on kinetoplastid disease drug development published
Hendrickx, S.*, Ilbeigi, K.*, Thoré, E.S.J., Bertram, M.G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A.I., Corral, M.J., Mateo-Barrientos, M., Estaquier, J., Pomel, S., Alunda, J.M., Gul, S., Van Bocxlaer, K., Frézard, F., Tavares, J., Cordeiro da Silva, A., Costi, M.P., Maes, L.†, Caljon, G.† 2026. A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage. J. Antimicrob. Chemother. 81, dkag109. https://doi.org/10.1093/jac/dkag109 | PDF * Co-first authors. † Co-senior authors.
Hendrickx, S.*, Ilbeigi, K.*, Thoré, E.S.J., Bertram, M.G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A.I., Corral, M.J., Mateo-Barrientos, M., Estaquier, J., Pomel, S., Alunda, J.M., Gul, S., Van Bocxlaer, K., Frézard, F., Tavares, J., Cordeiro da Silva, A., Costi, M.P., Maes, L.†, Caljon, G.† 2026. A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit. J. Antimicrob. Chemother. 81, dkag110. https://doi.org/10.1093/jac/dkag110 | PDF * Co-first authors. † Co-last authors.
Hendrickx, S.*, Ilbeigi, K.*, Thoré, E.S.J., Bertram, M.G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A.I., Corral, M.J., Mateo-Barrientos, M., Estaquier, J., Pomel, S., Alunda, J.M., Gul, S., Van Bocxlaer, K., Frézard, F., Tavares, J., Cordeiro da Silva, A., Costi, M.P., Maes, L.†, Caljon, G.† 2026. A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards drug development candidate. J. Antimicrob. Chemother. 81, dkag111. https://doi.org/10.1093/jac/dkag111 | PDF * Co-first authors. † Co-last authors.
